BSTG - Biostage, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
0
0
0
0
0
Cost of Revenue
-
-
-
0
-
Gross Profit
0
0
-
0
0
Operating Expense
10,561
6,153
8,471
4,878
8,397
Operating Income
-10,561
-6,153
-8,471
-4,878
-8,397
Other Income Expense
110
80
493
13
65
Pretax Income
-10,451
-6,073
-7,978
-4,865
-8,332
Net Income Common Stockholders
-10,546
-6,253
-7,978
-4,865
-8,332
Diluted NI Available to Com Stockholders
-10,546
-6,253
-7,978
-4,865
-8,332
Basic EPS
-
-
-0.79
-0.55
-1.21
Diluted EPS
-
-
-0.79
-0.55
-1.21
Basic Average Shares
-
-
10,062
8,794
6,898
Diluted Average Shares
-
-
10,062
8,794
6,898
Total Operating Income as Reported
-10,561
-6,153
-8,636
-5,325
-8,870
Total Expenses
10,561
6,153
8,471
4,878
8,397
Net Income from Continuing & Discontinued Operation
-10,451
-6,073
-7,978
-4,865
-8,332
Normalized Income
-10,482
-6,075
-8,401
-4,881
-8,397
EBIT
-10,561
-6,153
-8,471
-4,878
-8,397
EBITDA
-10,501
-
-
-
-
Reconciled Cost of Revenue
-
-
-
0
-
Reconciled Depreciation
60
52
107
184
311
Net Income from Continuing Operation Net Minority Interest
-10,451
-6,073
-7,978
-4,865
-8,332
Total Unusual Items Excluding Goodwill
31
2
423
16
65
Total Unusual Items
31
2
423
16
65
Normalized EBITDA
-10,532
-6,103
-8,894
-4,710
-8,151
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0

Yahoo Finance Plus Essential access required.

Learn more